# Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

> **NCT01894477** · PHASE2 · UNKNOWN · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 102 (actual)

## Conditions studied

- Acute Myeloid Leukemia in Remission
- Chronic Myelomonocytic Leukemia
- Minimal Residual Disease
- Myelodysplastic Syndrome
- Myelodysplastic/Myeloproliferative Neoplasm
- Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable

## Interventions

- **PROCEDURE:** Allogeneic Bone Marrow Transplantation
- **DRUG:** Fludarabine Phosphate
- **PROCEDURE:** Peripheral Blood Stem Cell Transplantation
- **RADIATION:** Total-Body Irradiation
- **DRUG:** Treosulfan
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT01894477
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2017-01-09
- **Final completion:** 2022-06
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2021-06-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01894477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01894477, "Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01894477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*